-
1.发明公开
公开(公告)号：EP2148672A1
公开(公告)日：2010-02-03
申请号：EP08735139.1
申请日：2008-04-10
申请人： Bayer HealthCare AG
发明人： VON DEGENFELD, Georges , KLEIN, Martina , PERZBORN, Elisabeth , HÜTTER, Joachim , WEIMANN, Gerrit
IPC分类号： A61K31/421 , A61P9/12
CPC分类号： A61K31/421 , A61K31/422 , A61K31/5377
摘要： The present invention relates to the use of factor Xa inhibitors, particularly oxazolidinones of formula (I) for the treatment and/or prophylaxis of pulmonary hypertension, and the use thereof for producing medications for the treatment and/or prophylaxis of pulmonary hypertension.
-
公开(公告)号：EP2079708A2
公开(公告)日：2009-07-22
申请号：EP07818862.0
申请日：2007-10-10
申请人： Bayer HealthCare AG
发明人： BAUSER, Marcus , BUCHMÜLLER, Anja , VON DEGENFELD, Georges , DITTRICH-WENGENROTH, Elke , GERDES, Christoph , GNOTH, Mark, Jean , GOTTSCHLING, Dirk , HEITMEIER, Stefan , HENDRIX, Martin , KÖBBERLING, Johannes , LANG, Dieter , RESTER, Ulrich , SAATMANN, Uwe , TERSTEEGEN, Adrian , BRÜNS, Astrid
IPC分类号： C07D233/88
CPC分类号： C07D233/88 , C07D277/20 , C07D401/14 , C07D403/04 , C07D405/14 , C07D417/12
摘要： The invention relates to acyl aminoimidazoles and acyl aminothiazoles, to a method for producing same and to the use thereof for producing medicaments for the treatment and/or prevention of diseases, in particular cardiovascular diseases, preferably thromboembolic diseases.
摘要翻译： 本发明涉及酰基氨基咪唑和酰基氨基噻唑，其制备方法及其用于制备用于治疗和/或预防疾病，特别是心血管疾病，优选血栓栓塞性疾病的药物。
-
3.发明公开SUBSTITUIERTE (OXAZOLIDINON-5-YL-METHYL) -2-THIOPHEN-CARBOXAMIDE UND IHRE VERWENDUNG IM GEBIET DER BLUTGERINNUNG 有权SUBSTITUIERTE（恶唑烷酮-5-基 - 甲基）-2-噻吩 - 甲酰胺和IHRE VERWENDUNG IM GEBIET DER BLUTGERINNUNG
公开(公告)号：EP2173744A1
公开(公告)日：2010-04-14
申请号：EP08759099.8
申请日：2008-06-07
申请人： Bayer HealthCare AG
发明人： ALLERHEILIGEN, Swen , BAUSER, Marcus , SCHIROK, Hartmut , RESTER, Ulrich , HEITMEIER, Stefan , GERDES, Christoph , VON DEGENFELD, Georges , DITTRICH-WENGENROTH, Elke , SAATMANN, Uwe , STRASSBURGER, Julia , MÜNTER, Klaus , GNOTH, Mark, Jean , LANG, Dieter
IPC分类号： C07D413/14 , A61K31/4439 , A61P7/00
CPC分类号： C07D413/14
摘要： The invention relates to novel substituted oxazolidinones, methods for the production thereof, use thereof for treating and/or for the prophylaxis of diseases and use thereof for producing medicaments for treating and/or for the prophylaxis of diseases, in particular thromboembolic disorders.
摘要翻译： 本发明涉及新的取代的恶唑烷酮，其制备方法，其用于治疗和/或预防疾病的用途以及用于制备用于治疗和/或预防疾病，特别是血栓栓塞性疾病的药物的用途。
-
4.发明公开SUBSTITUIERTE (OXAZOLIDINON-5-YL-METHYL) -2-THIOPHEN-CARBOXAMIDE UND IHRE VERWENDUNG IM GEBIET DER BLUTGERINNUNG 有权取代的（恶唑烷酮-5-基 - 甲基）-2-噻吩甲酰胺和它们在血液凝固领域
公开(公告)号：EP2170877A1
公开(公告)日：2010-04-07
申请号：EP08773372.1
申请日：2008-06-07
申请人： Bayer HealthCare AG
发明人： ALLERHEILIGEN, Swen , BAUSER, Marcus , HEIMBACH, Dirk , HEITMEIER, Stefan , GNOTH, Mark, Jean , GERDES, Christoph , VON DEGENFELD, Georges , RÖHRIG, Susanne , RESTER, Ulrich , DITTRICH-WENGENROTH, Elke , SAATMANN, Uwe , TERSTEEGEN, Adrian
IPC分类号： C07D413/14 , A61K31/4439 , A61P7/00
CPC分类号： C07D413/14
摘要： The invention relates to novel substituted oxazolidinones, methods for the production thereof, use thereof for treating and/or for the prophylaxis of diseases and use thereof for producing medicaments for treating and/or for the prophylaxis of diseases, in particular thromboembolic disorders.
-
-
-
搜索结果
4 条记录 (耗时 0.015 秒)
